Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial investigating safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK3335065 IV infusion in healthy adults; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis Acute Necrotizing

Drugs mentioned

• GSK3335065

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pancreatitis, Acute Necrotizing | Phase 1 | Status: TERMINATED | Results posted: 2019-09-20